文献速递妇科

子宫肌瘤的非手术治疗

Non-surgical Management of Myomas.
PubMed 文献 · J Minim Invasive Gynecol · 2017-08-15

本文综述子宫肌瘤保留子宫的非手术治疗选择,从药物治疗到微创操作,并评估症状改善的持续性和对未来生育的影响。未来研究可能带来降低大手术风险、减少副作用及提供一级或二级预防的疗法。

要点

  • 子宫肌瘤常见且是子宫切除术的首要原因。
  • 肌瘤症状从无症状到严重致残不等,许多女性在完成生育前发病。
  • 女性常寻求保留子宫的非手术治疗。

核心结论

  • 综述讨论了子宫肌瘤从药物治疗到微创操作的保留子宫治疗选择,并评估症状改善的持续性和对未来生育的影响。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • 子宫肌瘤是常见疾病,也是子宫切除术的首要原因。
  • 肌瘤症状范围从无症状到严重致残,且许多女性在完成生育前发病。
  • 女性常寻求保留子宫的非手术治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Uterine myomas are a common condition and the leading cause of hysterectomy. Clinically, myomas can be challenging because they range from asymptomatic to causing severe, debilitating symptoms and occur in many women before childbearing is complete. Thus, women often seek uterine-conserving and nonsurgical management of their myomas. In this review the available uterine-conserving treatment options from medical management through minimally invasive procedures are discussed. To the extent of research available, the sustainability of symptom improvement and the effects on future fertility are reviewed. Future research may lead to therapies that reduce the risks of major surgery, decrease side effects, and offer primary or secondary prevention options.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Laughlin-Tommaso SK. Non-surgical Management of Myomas. J Minim Invasive Gynecol. 2017. PMID: 28821471. doi:10.1016/j.jmig.2017.08.642

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。